Subcutaneous Biologics Market Global Forecasts to 2035: Leading Players & Sales Forecast for Adocia, Alteogen, Ascendis Pharma, CD Bioparticles, Creative Biolabs, Pacira Biosciences & Xeris Biopharma - ResearchAndMarkets.com
21 Jan 2025 14:30 GMT
… Top Approved Subcutaneous Biologics
BENLYSTA (Human Genome Sciences)
BESREMi (PharmaEssentia)
COSENTYX (Novartis)
DARZALEX …
Subcutaneous Biologics Market, Industry Trends And Global Forecasts To 2035: Subcutaneous Biologics Set To Transform Drug Delivery And Patient Adherence
16 Jan 2025 13:02 GMT
… Top Approved Subcutaneous Biologics BENLYSTA (Human Genome Sciences) BESREMi (PharmaEssentia) COSENTYX (Novartis) DARZALEX …
Unlocking Extensive Growth Opportunities of Vasculitis Treatment Market by 2031 | RNL BIO Co., Ltd., GlaxoSmithKline plc
09 Jan 2025 09:28 GMT
…
• Novartis AG
• Troikaa Pharmaceuticals Ltd.
• Human Genome Sciences Inc.¸ Genentech Inc.
• F. Hoffmann …
Ronald Henri Shiftan
03 Jan 2025 01:30 GMT
… Institute for Genetic Research and Human Genome Sciences Inc.
In the public sector …
Human Genome Sciences Raises $100 Million from Private Offering
21 Sep 2019 11:05 GMT
… adjustment in certain circumstances.
Human Genome Sciences plans to use the … facility.
General corporate purposes.
Human Genome Sciences develops pharmaceutical products to … William A. Haseltine, CEO, Human Genome Sciences, 9410 Key West Ave., Rockville …
DPR life sciences lead bullish on growth, AI
12 Dec 2024 15:55 GMT
… .
I am proud of the Human Genome Sciences Large Scale Manufacturing project in …
Nouscom Appoints Seasoned Executive Eckhard Niemeier as Chief Business Officer
03 Dec 2024 08:00 GMT
… and completed his thesis at Human Genome Sciences. Mr. Eckhard Niemeier, CBO, added …